This is a sequel to the Western India Pharmaceutical Company (M) case in which issues were raised as to what would be the appropriate pricing strategies for a small unit to fight with large multinationals. This case deals with problems of price competition faced by the same unit from still smaller units. The philosophical issues related to competing on a price vs. nonprice basis (i.e., use of brand name, e.tc) are raised. How "price" is used as the major marketing mix element by small units is illustrated.